Cancer Research Technology
Log in Register
Menu
Search
Cell Lines

HeLa pCDH-CMV-MCS-EF1-copGFP Control Cell Line

Invented by Peter Bradding , Harvinder Virk
Invented at University Of Leicester
  • Datasheet
  • Inventor Info
Print

Info

Catalogue Number 160703
Antigen/Gene or Protein Targets GFP
Parental Line HeLa cervical cancer cell line
Relevance This cell line is a negative control for the TRPA1 and TRPM2 cell lines developed by Prof Peter Bradding and Dr Harvinder Virk at University of Leicester (see Related tab).

This HeLa cell line is stably transfected with the dual-gene promotor pCDH-CMV-MCS-EF1-copGFP vector without carrying a gene of interest.
Conditional No
Research Area Neurobiology

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Virk et al. 2019. Sci Rep. 9(1):18500. PMID: 31811235.

View  

Add a reference

References: 1 entry

Virk et al. 2019. Sci Rep. 9(1):18500. PMID: 31811235.

View  

Add a reference

Inventor Information

Inventors

Peter Bradding

Peter Bradding

Harvinder Virk

Harvinder Virk

Add an inventor

Invented at

University Of Leicester
University Of Leicester

20 reagents listed on Ximbio